From: Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome
Patient characteristic | No. of patients (%) |
---|---|
All | 110 (100) |
Age | |
Median | 52 |
Range | 26--73 |
Gender | |
Male | 71 (64.5) |
Female | 39 (35.5) |
Histology | |
WHO type I | 3 (2.7) |
WHO type II | 84 (76.4) |
WHO type III | 23 (20.9) |
Performance status (ECOG) | |
0 | 103 (93.6) |
1 | 4 (3.6) |
2 | 3 (2.7) |
AJCC 1997 T stage | |
1 | 20 (18.2) |
2 | 35 (31.8) |
3 | 23 (20.9) |
4 | 32 (29.1) |
AJCC 1997 N stage | |
0 | 2 (1.8) |
1 | 3 (2.7) |
2 | 75 (68.2) |
3 | 30 (27.3) |
AJCC 1997 Stage group | |
III | 61 (55.5) |
IV | 49 (44.5) |